About Gujarat Terce Laboratories Limited
Data last updated: 31 December 2025
Gujarat Terce Laboratories Limited is a public limited company based in Gandhinagar, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 March 1985, the company has been in operation for over 41 years.
Registered with ROC Ahmedabad under CIN L24100GJ1985PLC007753. Listed on BSE: 524314.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹7.79 Cr. It is led by directors including Avani Sandip Solanki and Prajapati Aalap Natubhai.
Last AGM: 21 August 2025. Financial statements filed for year ended 31 March 2025. Office: 122/2 Ravi Estate Bileshwarpura Chhtral, Gandhinagar, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.5 Cr, a growth of 5% compared to the previous year.
The company has a workforce of approximately 260 employees as per the latest available data.
The company is associated with 1 brand - Gujarat Terce Laboratories. As per MCA filings, the company has open charges of ₹9.15 Cr and satisfied charges of ₹8.98 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gujaratterce.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address122/2 Ravi Estate Bileshwarpura Chhtral, Gandhinagar, Gujarat, India – 382729
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ1985PLC007753, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ1985PLC007753 | Current |
| L24230GJ1985PLC007753 | Previous |
| L28112GJ1985PLC007753 | Previous |
Associated Brands with Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited operates one associated brand: Gujarat Terce Laboratories. These brands represent Gujarat Terce Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and distribution of pharmaceutical products in India. | gujaratterce.in |
Business Activity of Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited is audited by Shah Doshi Patel & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Shah Doshi Patel & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited is currently managed by 9 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Avani Sandip Solanki
Also directs:
Gujarat Terce Laboratories Limited, Dynemic Products Limited
|
Director | 26 May 2025 | 1 Years 1 Months | Current |
| Prajapati Aalap Natubhai | Managing Director | 01 Apr 2018 | 8 Years 3 Months | Current |
|
Navinchandra Patel
Also directs:
Gujarat Terce Laboratories Limited
|
Director | 26 Feb 2020 | 6 Years 4 Months | Current |
|
Prajapati Natwarbhai Parsottam
Also directs:
Gujarat Terce Laboratories Limited
|
Whole-Time Director | 28 Mar 1985 | 41 Years 3 Months | Current |
|
Surendrakumar Prakashchandra Sharma
Also directs:
Gujarat Terce Laboratories Limited
|
Director | 10 Aug 2018 | 7 Years 11 Months | Current |
|
Amritbhai Purshottamdas Prajapati
Also directs:
Gujarat Terce Laboratories Limited
|
Whole-Time Director | 01 Mar 2006 | 20 Years 4 Months | Current |
Financials of Gujarat Terce Laboratories Limited FY 2026 filings available
Gujarat Terce Laboratories Limited reported revenue of ₹47.47 Cr (down 5.42% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹47.47 Cr | ₹50.2 Cr | ₹47.97 Cr | ₹46.78 Cr | ₹40.13 Cr | ₹25.18 Cr | ₹37.54 Cr | ₹31.03 Cr |
| Other Income | ₹34.04 Lakh | ₹30.78 Lakh | ₹32.1 Lakh | ₹35.45 Lakh | ₹30.6 Lakh | ₹80.21 Lakh | ₹28.61 Lakh | ₹32.48 Lakh |
| Total Income | ₹47.81 Cr | ₹50.5 Cr | ₹48.3 Cr | ₹47.14 Cr | ₹40.44 Cr | ₹25.98 Cr | ₹37.83 Cr | ₹31.36 Cr |
| Cost of Materials Consumed | ₹6.07 Cr | ₹9.14 Cr | ₹7.58 Cr | ₹6.04 Cr | ₹7.11 Cr | ₹3.44 Cr | ₹5.17 Cr | ₹3.32 Cr |
| Purchases of Stock-in-Trade | ₹11.48 Cr | ₹10.15 Cr | ₹9.07 Cr | ₹11.67 Cr | ₹10.77 Cr | ₹6.81 Cr | ₹9.11 Cr | ₹8.02 Cr |
| Changes in Inventories | -₹42.15 Lakh | -₹38.14 Lakh | ₹1.04 Cr | ₹1.65 Cr | -₹2.63 Cr | -₹25.79 Lakh | -₹37.49 Lakh | ₹18.53 Lakh |
| Employee Benefit Expense | ₹16.07 Cr | ₹16.19 Cr | ₹15.78 Cr | ₹20.6 Cr | ₹15.83 Cr | ₹12.97 Cr | ₹15.13 Cr | ₹12.82 Cr |
| Finance Costs | ₹17.95 Lakh | ₹41.54 Lakh | ₹67.6 Lakh | ₹72.14 Lakh | ₹40.09 Lakh | ₹38.93 Lakh | ₹29.18 Lakh | ₹25.39 Lakh |
| Depreciation & Amortisation | ₹42.27 Lakh | ₹38.46 Lakh | ₹36.78 Lakh | ₹36.45 Lakh | ₹27.59 Lakh | ₹17.63 Lakh | ₹24.15 Lakh | ₹21.14 Lakh |
| Other Expenses | ₹10.52 Cr | ₹11.21 Cr | ₹13.24 Cr | ₹9 Cr | ₹7.94 Cr | ₹4.99 Cr | ₹7.83 Cr | ₹6.2 Cr |
| Total Expenses | ₹44.33 Cr | ₹47.11 Cr | ₹47.75 Cr | ₹50.03 Cr | ₹39.69 Cr | ₹28.51 Cr | ₹37.39 Cr | ₹31.01 Cr |
| Profit Before Exceptional Items & Tax | ₹3.49 Cr | ₹3.39 Cr | ₹54.39 Lakh | -₹2.89 Cr | ₹74.66 Lakh | -₹2.53 Cr | ₹43.59 Lakh | ₹34.57 Lakh |
| Exceptional Items | -₹45.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹3.03 Cr | ₹3.39 Cr | ₹54.39 Lakh | -₹2.89 Cr | ₹74.66 Lakh | -₹2.53 Cr | ₹43.59 Lakh | ₹34.57 Lakh |
| Total Tax Expense | ₹83.06 Lakh | ₹4.37 Cr | ₹30.05 Lakh | -₹1.22 Cr | -₹12.57 Lakh | -₹1.14 Lakh | ₹15.98 Lakh | -₹8.68 Lakh |
| Net Profit | ₹2.2 Cr | -₹97.87 Lakh | ₹24.34 Lakh | -₹1.67 Cr | ₹87.23 Lakh | -₹2.52 Cr | ₹27.61 Lakh | ₹43.25 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹2.2 Cr | -₹97.87 Lakh | ₹24.34 Lakh | -₹1.67 Cr | ₹87.23 Lakh | -₹2.52 Cr | ₹27.61 Lakh | ₹43.25 Lakh |
| EBITDA (computed) | ₹4.09 Cr | ₹4.19 Cr | ₹1.59 Cr | -₹1.81 Cr | ₹1.42 Cr | -₹1.97 Cr | ₹96.92 Lakh | ₹81.1 Lakh |
| Basic EPS | ₹2.92 | ₹-1.31 | ₹0.33 | ₹-2.25 | ₹1.18 | ₹-3.40 | ₹0.37 | ₹0.06 |
| Diluted EPS | ₹2.92 | ₹-1.26 | ₹0.33 | ₹-2.25 | ₹1.18 | ₹-3.40 | ₹0.37 | ₹0.06 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹24.55 Cr | ₹22.83 Cr | ₹23.27 Cr | ₹28.53 Cr | ₹27.39 Cr | ₹21.8 Cr | ₹22.34 Cr | ₹19.34 Cr |
| Non-current Assets | ₹10.14 Cr | ₹10.8 Cr | ₹12.05 Cr | ₹12.48 Cr | ₹11.92 Cr | ₹9.85 Cr | ₹10.43 Cr | ₹10.12 Cr |
| Current Assets | ₹14.41 Cr | ₹12.02 Cr | ₹11.22 Cr | ₹16.05 Cr | ₹15.48 Cr | ₹11.95 Cr | ₹11.91 Cr | ₹9.22 Cr |
| Property, Plant & Equipment | ₹3.25 Cr | ₹3.65 Cr | ₹3.69 Cr | ₹3.99 Cr | ₹4.29 Cr | ₹2.45 Cr | ₹7.62 Cr | ₹7.38 Cr |
| Inventories | ₹3.73 Cr | ₹3.68 Cr | ₹3.98 Cr | ₹4.43 Cr | ₹6.43 Cr | ₹3.74 Cr | ₹3.43 Cr | ₹3.78 Cr |
| Trade Receivables | ₹4.87 Cr | ₹5.07 Cr | ₹5.66 Cr | ₹7.99 Cr | ₹5.47 Cr | ₹5.1 Cr | ₹7.01 Cr | ₹4.53 Cr |
| Cash & Equivalents | ₹2.86 Cr | ₹77.94 Lakh | ₹9.01 Lakh | ₹2.03 Cr | ₹92,000 | ₹1.29 Cr | ₹4.17 Lakh | ₹18.27 Lakh |
| Equity (Net Worth) | ₹9.73 Cr | ₹6.48 Cr | ₹7.11 Cr | ₹6.86 Cr | ₹8.53 Cr | ₹7.66 Cr | ₹11.11 Cr | ₹10.83 Cr |
| Equity Share Capital | ₹7.79 Cr | ₹7.42 Cr | ₹7.42 Cr | ₹7.42 Cr | ₹7.42 Cr | ₹7.42 Cr | ₹7.42 Cr | ₹7.42 Cr |
| Borrowings (Non-current) | ₹3 Lakh | ₹29.77 Lakh | ₹92.74 Lakh | ₹1.46 Cr | ₹2.3 Cr | ₹42.48 Lakh | ₹15.52 Lakh | ₹12.79 Lakh |
| Borrowings (Current) | ₹1.27 Cr | ₹64.41 Lakh | ₹2.94 Cr | ₹5.81 Cr | ₹4.37 Cr | ₹4.14 Cr | ₹2.38 Cr | ₹52.31 Lakh |
| Total Debt (computed) | ₹1.3 Cr | ₹94.18 Lakh | ₹3.87 Cr | ₹7.27 Cr | ₹6.67 Cr | ₹4.57 Cr | ₹2.53 Cr | ₹65.1 Lakh |
| Current Liabilities | ₹10.95 Cr | ₹12.64 Cr | ₹12.14 Cr | ₹16.61 Cr | ₹13.21 Cr | ₹11.64 Cr | ₹9.28 Cr | ₹6.67 Cr |
| Total Liabilities | ₹14.82 Cr | ₹16.35 Cr | ₹16.17 Cr | ₹21.66 Cr | ₹18.86 Cr | ₹14.14 Cr | ₹11.23 Cr | ₹8.5 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹1.71 Cr | ₹3.06 Cr | ₹2.6 Cr | ₹2.67 Lakh | -₹44.33 Lakh |
| Investing Cash Flow | -₹10.79 Lakh | ₹45.54 Lakh | -₹45.79 Lakh | ₹61.51 Lakh | -₹2.37 Cr |
| Financing Cash Flow | ₹47.37 Lakh | -₹2.83 Cr | -₹4.08 Cr | -₹12.11 Lakh | ₹1.53 Cr |
| Capital Expenditure | ₹3.05 Lakh | -₹34.69 Lakh | ₹7.37 Lakh | ₹6.31 Lakh | ₹2.11 Cr |
| Free Cash Flow (computed) | ₹1.68 Cr | ₹2.71 Cr | ₹2.53 Cr | -₹3.64 Lakh | -₹2.56 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹2.08 Cr | ₹68.94 Lakh | -₹1.94 Cr | ₹52.07 Lakh | -₹1.28 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹11.4 Cr | ₹12.29 Cr | ₹12.93 Cr | ₹10.85 Cr | ₹12.32 Cr | ₹12.68 Cr | ₹13.3 Cr | ₹11.89 Cr |
| Other Income | ₹7.66 Lakh | ₹12.67 Lakh | ₹5.52 Lakh | ₹9.48 Lakh | ₹8.67 Lakh | ₹6.73 Lakh | ₹8.05 Lakh | ₹7.33 Lakh |
| Total Income | ₹11.48 Cr | ₹12.42 Cr | ₹12.98 Cr | ₹10.95 Cr | ₹12.41 Cr | ₹12.75 Cr | ₹13.38 Cr | ₹11.96 Cr |
| Cost of Materials Consumed | ₹70.79 Lakh | ₹2.08 Cr | ₹1.3 Cr | ₹1.98 Cr | ₹3.06 Cr | ₹1.88 Cr | ₹1.2 Cr | ₹3 Cr |
| Purchases of Stock-in-Trade | ₹3.31 Cr | ₹2.83 Cr | ₹2.75 Cr | ₹2.59 Cr | ₹2.67 Cr | ₹2.84 Cr | ₹1.65 Cr | ₹2.98 Cr |
| Changes in Inventories | -₹12.37 Lakh | -₹41.4 Lakh | ₹26.93 Lakh | -₹15.31 Lakh | -₹22.24 Lakh | -₹24.63 Lakh | ₹1.37 Cr | -₹1.28 Cr |
| Employee Benefit Expense | ₹4.12 Cr | ₹4.03 Cr | ₹4.17 Cr | ₹3.75 Cr | ₹4.17 Cr | ₹3.98 Cr | ₹4.21 Cr | ₹3.84 Cr |
| Finance Costs | ₹2.53 Lakh | ₹3.99 Lakh | ₹6.5 Lakh | ₹4.93 Lakh | ₹6.86 Lakh | ₹8.45 Lakh | ₹13.4 Lakh | ₹12.83 Lakh |
| Depreciation & Amortisation | ₹13.43 Lakh | ₹9.61 Lakh | ₹9.62 Lakh | ₹9.61 Lakh | ₹10.25 Lakh | ₹9.53 Lakh | ₹9.44 Lakh | ₹9.24 Lakh |
| Other Expenses | ₹2.65 Cr | ₹2.62 Cr | ₹2.55 Cr | ₹2.7 Cr | ₹1.6 Cr | ₹3.13 Cr | ₹3.22 Cr | ₹3.27 Cr |
| Total Expenses | ₹10.82 Cr | ₹11.29 Cr | ₹11.2 Cr | ₹11.02 Cr | ₹11.44 Cr | ₹11.77 Cr | ₹11.87 Cr | ₹12.03 Cr |
| Profit Before Exceptional Items & Tax | ₹65.86 Lakh | ₹1.13 Cr | ₹1.78 Cr | -₹7.1 Lakh | ₹96.83 Lakh | ₹97.78 Lakh | ₹1.51 Cr | -₹6.94 Lakh |
| Exceptional Items | -₹45.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹20.47 Lakh | ₹1.13 Cr | ₹1.78 Cr | -₹7.1 Lakh | ₹96.83 Lakh | ₹97.78 Lakh | ₹1.51 Cr | -₹6.94 Lakh |
| Total Tax Expense | ₹10.37 Lakh | ₹36.7 Lakh | ₹37.98 Lakh | -₹2.75 Lakh | ₹4.36 Cr | -₹3.03 Lakh | ₹3.15 Lakh | ₹82,000 |
| Net Profit | ₹10.1 Lakh | ₹76.11 Lakh | ₹1.4 Cr | -₹4.35 Lakh | -₹3.39 Cr | ₹1.01 Cr | ₹1.48 Cr | -₹7.76 Lakh |
| Other Comprehensive Income | ₹0 | -₹2.05 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹10.1 Lakh | ₹74.06 Lakh | ₹1.4 Cr | -₹4.35 Lakh | -₹3.39 Cr | ₹1.01 Cr | ₹1.48 Cr | -₹7.76 Lakh |
| EBITDA (computed) | ₹81.82 Lakh | ₹1.26 Cr | ₹1.94 Cr | ₹7.44 Lakh | ₹1.14 Cr | ₹1.16 Cr | ₹1.74 Cr | ₹15.13 Lakh |
| Basic EPS | ₹0.13 | ₹0.95 | ₹1.89 | ₹-0.06 | ₹-4.57 | ₹1.36 | ₹2.00 | ₹-0.10 |
| Diluted EPS | ₹0.13 | ₹0.95 | ₹1.80 | ₹-0.06 | ₹-4.35 | ₹1.36 | ₹2.00 | ₹-0.10 |
Shareholding Pattern of Gujarat Terce Laboratories Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 40.03%, retail and other public shareholders hold 59.97% of Gujarat Terce Laboratories Limited. The company had 13,750 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 40.03% | 40.03% | 37.03% | 37.03% | 37.03% | 37.03% |
| Public | 59.97% | 59.97% | 62.97% | 62.97% | 62.97% | 62.97% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 40.03% | 37.03% | 37.03% |
| Public | 59.97% | 62.97% | 62.97% |
| Promoter change (YoY, %pts) | +3.00 | +0.00 | - |
Charges & Borrowings of Gujarat Terce Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2021 | Hdfc Bank Limited | ₹36.12 Lakh | Open |
| 08 Jul 2006 | Others | ₹8.79 Cr | Open |
| 30 May 1995 | Bank of Baroda | ₹2.14 Cr | Satisfied |
| 05 Jan 1995 | Bank of Baroda | ₹4.33 Cr | Satisfied |
| 05 Jan 1995 | Bank of Baroda | ₹58 Lakh | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited has a workforce of 260 employees as of May 20, 2025.
Employee Count & EPFO Data of Gujarat Terce Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Gujarat Terce Laboratories Limited
GSTIN & GST Filing Data of Gujarat Terce Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Gujarat Terce Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Gujarat Terce Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Gujarat Terce Laboratories Limited
MSME Payment Delays by Gujarat Terce Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Gujarat Terce Laboratories Limited
Subsidiaries & Group Companies of Gujarat Terce Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Gujarat Terce Laboratories Limited with ownership details.
MCA Filings & Documents of Gujarat Terce Laboratories Limited
MCA Filings & Documents of Gujarat Terce Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Gujarat Terce Laboratories Limited
Recent News on Gujarat Terce Laboratories Limited
Frequently Asked Questions about Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited is an active public limited company in the pharma sector based in Gandhinagar, Gujarat, India. It was incorporated on 28 March 1985 (41+ years old) and is registered under CIN L24100GJ1985PLC007753. Listed on BSE: 524314. The company has 260 employees.
Gujarat Terce Laboratories Limited reported revenue of ₹50.5 Cr for FY 2025 (up 5.00% YoY).
The current directors of Gujarat Terce Laboratories Limited are:
- Avani Sandip Solanki
- Prajapati Aalap Natubhai
- Navinchandra Patel
- Ripalben Sachinkumar Sukhadiya
- Bhagirath Ramhit Maurya
- Prajapati Natwarbhai Parsottam
- Surendrakumar Prakashchandra Sharma
- Amritbhai Purshottamdas Prajapati
- Viplav Suryakantbhai Khamar
The primary industry of Gujarat Terce Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Gujarat Terce Laboratories Limited is listed on BSE with code 524314.
Gujarat Terce Laboratories Limited can be reached at the registered office: 1222 Ravi Estate Bileshwarpura Chhtral, Gandhinagar, Gujarat, India – 382729, or through the website gujaratterce.in.